Remix Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Remix Therapeutics's estimated annual revenue is currently $12.6M per year.
- Remix Therapeutics's estimated revenue per employee is $155,000
- Remix Therapeutics's total funding is $81M.
Employee Data
- Remix Therapeutics has 81 Employees.
- Remix Therapeutics grew their employee count by -1% last year.
Remix Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder, President and CEO | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
3 | SVP, Head Drug Discovery at Remix Therapeutics | Reveal Email/Phone |
4 | VP, Human Resources | Reveal Email/Phone |
5 | VP, Biological Exploration and Translational Research | Reveal Email/Phone |
6 | VP, Program Management | Reveal Email/Phone |
7 | Head Medicinal Chemistry | Reveal Email/Phone |
8 | VP, Development Operations & Patient Advocacy | Reveal Email/Phone |
9 | SVP, Biomolecular Sciences and Lead Discovery | Reveal Email/Phone |
10 | SVP, in silico & in vivo Biosciences | Reveal Email/Phone |
Remix Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Remix Therapeutics?
Remix Therapeutics is a biotechnology company developing novel small molecule therapies designed to reprogram RNA processing and treat disease in entirely new ways.
keywords:N/A
$81M
Total Funding
81
Number of Employees
$12.6M
Revenue (est)
-1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Remix Therapeutics News
... Johnson & Johnson's unit, partnered with Remix Therapeutics, a biotech company developing small molecule therapies designed to reprogram...
emix Therapeutics is a biotechnology company developing novel small molecule therapies designed to reprogram RNA processing and treat disease in...
Biotechnology startup Remix Therapeutics Inc. has secured $81 million from venture capitalists to develop medications that could treat a variety of diseases by influencing how cells process RNA. Most drugs interact with disease proteins. Remix and some other startups instead seek to influence R ...
Drugs normally target problematic proteins, but Peter Smith, Ph.D., believes his team at Remix Therapeutics can disrupt the process of a protein’s creation before it starts causing disease. Investors believe in him, too—the company launches with $81 million in funding to develop small molecules ...
Biotechnology startup Remix Therapeutics Inc. has secured $81 million from venture capitalists to develop medications that could treat a variety of diseases by influencing how cells process RNA. Most drugs interact with disease proteins. Remix and some other startups instead seek to influence R ...
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $14.6M | 81 | 19% | N/A |
#2 | $11.9M | 82 | -44% | $19.5M |
#3 | $12.7M | 82 | -41% | N/A |
#4 | $12.7M | 82 | 32% | $283M |
#5 | $11.9M | 82 | N/A | N/A |